Wetzel Investment Advisors, Inc. Infla Rx N.V. Transaction History
Wetzel Investment Advisors, Inc.
- $176 Million
- Q1 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Infla Rx N.V. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 2,000 shares of IFRX stock, worth $3,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 1,000
100.0%
Holding current value
$3,280
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IFRX
# of Institutions
40Shares Held
13.8MCall Options Held
12.9KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY5.73MShares$9.4 Million0.38% of portfolio
-
Eversept Partners, LP New York, NY1.31MShares$2.14 Million0.15% of portfolio
-
Citigroup Inc1.2MShares$1.97 Million0.0% of portfolio
-
Morgan Stanley New York, NY979KShares$1.6 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY870KShares$1.43 Million0.11% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $72.5M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...